nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—Haematochezia—Varenicline—nicotine dependence	0.0757	0.0817	CcSEcCtD
Glipizide—Urine output increased—Varenicline—nicotine dependence	0.0276	0.0297	CcSEcCtD
Glipizide—Hypertonia—Varenicline—nicotine dependence	0.0267	0.0288	CcSEcCtD
Glipizide—Polyuria—Varenicline—nicotine dependence	0.0252	0.0272	CcSEcCtD
Glipizide—Eczema—Varenicline—nicotine dependence	0.0246	0.0266	CcSEcCtD
Glipizide—Libido decreased—Varenicline—nicotine dependence	0.0239	0.0258	CcSEcCtD
Glipizide—Visual disturbance—Varenicline—nicotine dependence	0.0234	0.0252	CcSEcCtD
Glipizide—Thirst—Varenicline—nicotine dependence	0.0233	0.0251	CcSEcCtD
Glipizide—Hypoglycaemia—Varenicline—nicotine dependence	0.0227	0.0245	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0221	0.0239	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.022	0.0237	CcSEcCtD
Glipizide—Migraine—Varenicline—nicotine dependence	0.0218	0.0235	CcSEcCtD
Glipizide—Abdominal pain upper—Varenicline—nicotine dependence	0.0202	0.0218	CcSEcCtD
Glipizide—Abdominal discomfort—Varenicline—nicotine dependence	0.0183	0.0198	CcSEcCtD
Glipizide—Photosensitivity reaction—Varenicline—nicotine dependence	0.0175	0.0188	CcSEcCtD
Glipizide—Conjunctivitis—Varenicline—nicotine dependence	0.0166	0.0179	CcSEcCtD
Glipizide—Hepatobiliary disease—Varenicline—nicotine dependence	0.0161	0.0174	CcSEcCtD
Glipizide—Hypoaesthesia—Varenicline—nicotine dependence	0.0152	0.0164	CcSEcCtD
Glipizide—Visual impairment—Varenicline—nicotine dependence	0.0148	0.0159	CcSEcCtD
Glipizide—Eye disorder—Varenicline—nicotine dependence	0.0143	0.0154	CcSEcCtD
Glipizide—Chills—Varenicline—nicotine dependence	0.0137	0.0148	CcSEcCtD
Glipizide—Arrhythmia—Varenicline—nicotine dependence	0.0137	0.0148	CcSEcCtD
Glipizide—Erythema—Varenicline—nicotine dependence	0.0133	0.0144	CcSEcCtD
Glipizide—Flatulence—Varenicline—nicotine dependence	0.0131	0.0142	CcSEcCtD
Glipizide—Muscle spasms—Varenicline—nicotine dependence	0.0128	0.0138	CcSEcCtD
Glipizide—Vision blurred—Varenicline—nicotine dependence	0.0126	0.0136	CcSEcCtD
Glipizide—Tremor—Varenicline—nicotine dependence	0.0125	0.0135	CcSEcCtD
Glipizide—Ill-defined disorder—Varenicline—nicotine dependence	0.0124	0.0133	CcSEcCtD
Glipizide—Malaise—Varenicline—nicotine dependence	0.012	0.013	CcSEcCtD
Glipizide—Vertigo—Varenicline—nicotine dependence	0.012	0.0129	CcSEcCtD
Glipizide—Syncope—Varenicline—nicotine dependence	0.012	0.0129	CcSEcCtD
Glipizide—Loss of consciousness—Varenicline—nicotine dependence	0.0117	0.0126	CcSEcCtD
Glipizide—KCNJ11—cardiovascular system—nicotine dependence	0.0116	0.198	CbGeAlD
Glipizide—Hypertension—Varenicline—nicotine dependence	0.0115	0.0124	CcSEcCtD
Glipizide—Myalgia—Varenicline—nicotine dependence	0.0114	0.0122	CcSEcCtD
Glipizide—Arthralgia—Varenicline—nicotine dependence	0.0114	0.0122	CcSEcCtD
Glipizide—Anxiety—Varenicline—nicotine dependence	0.0113	0.0122	CcSEcCtD
Glipizide—Discomfort—Varenicline—nicotine dependence	0.0112	0.0121	CcSEcCtD
Glipizide—Oedema—Varenicline—nicotine dependence	0.0109	0.0117	CcSEcCtD
Glipizide—Shock—Varenicline—nicotine dependence	0.0107	0.0115	CcSEcCtD
Glipizide—Thrombocytopenia—Varenicline—nicotine dependence	0.0107	0.0115	CcSEcCtD
Glipizide—ABCC8—cardiovascular system—nicotine dependence	0.0106	0.183	CbGeAlD
Glipizide—Hyperhidrosis—Varenicline—nicotine dependence	0.0105	0.0113	CcSEcCtD
Glipizide—Anorexia—Varenicline—nicotine dependence	0.0104	0.0112	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00992	0.0107	CcSEcCtD
Glipizide—Insomnia—Varenicline—nicotine dependence	0.00984	0.0106	CcSEcCtD
Glipizide—Dyspnoea—Varenicline—nicotine dependence	0.0097	0.0105	CcSEcCtD
Glipizide—Somnolence—Varenicline—nicotine dependence	0.00968	0.0104	CcSEcCtD
Glipizide—Dyspepsia—Varenicline—nicotine dependence	0.00958	0.0103	CcSEcCtD
Glipizide—Decreased appetite—Varenicline—nicotine dependence	0.00946	0.0102	CcSEcCtD
Glipizide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0094	0.0101	CcSEcCtD
Glipizide—Pain—Varenicline—nicotine dependence	0.00931	0.01	CcSEcCtD
Glipizide—Constipation—Varenicline—nicotine dependence	0.00931	0.01	CcSEcCtD
Glipizide—Feeling abnormal—Varenicline—nicotine dependence	0.00897	0.00967	CcSEcCtD
Glipizide—Gastrointestinal pain—Varenicline—nicotine dependence	0.0089	0.0096	CcSEcCtD
Glipizide—Urticaria—Varenicline—nicotine dependence	0.00865	0.00932	CcSEcCtD
Glipizide—Abdominal pain—Varenicline—nicotine dependence	0.0086	0.00928	CcSEcCtD
Glipizide—ABCC8—midbrain—nicotine dependence	0.00831	0.143	CbGeAlD
Glipizide—PPARG—cardiovascular system—nicotine dependence	0.00812	0.139	CbGeAlD
Glipizide—Hypersensitivity—Varenicline—nicotine dependence	0.00802	0.00865	CcSEcCtD
Glipizide—Asthenia—Varenicline—nicotine dependence	0.00781	0.00842	CcSEcCtD
Glipizide—Pruritus—Varenicline—nicotine dependence	0.0077	0.0083	CcSEcCtD
Glipizide—Diarrhoea—Varenicline—nicotine dependence	0.00745	0.00803	CcSEcCtD
Glipizide—Dizziness—Varenicline—nicotine dependence	0.0072	0.00776	CcSEcCtD
Glipizide—Vomiting—Varenicline—nicotine dependence	0.00692	0.00746	CcSEcCtD
Glipizide—Rash—Varenicline—nicotine dependence	0.00686	0.0074	CcSEcCtD
Glipizide—Dermatitis—Varenicline—nicotine dependence	0.00686	0.00739	CcSEcCtD
Glipizide—Headache—Varenicline—nicotine dependence	0.00682	0.00735	CcSEcCtD
Glipizide—Nausea—Varenicline—nicotine dependence	0.00646	0.00697	CcSEcCtD
Glipizide—KCNJ11—brain—nicotine dependence	0.00567	0.0973	CbGeAlD
Glipizide—ABCC8—brain—nicotine dependence	0.00522	0.0896	CbGeAlD
Glipizide—CYP2C9—cardiovascular system—nicotine dependence	0.00476	0.0816	CbGeAlD
Glipizide—PPARG—brain—nicotine dependence	0.00399	0.0684	CbGeAlD
Glipizide—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00164	0.113	CbGpPWpGaD
Glipizide—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00101	0.07	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNB3—nicotine dependence	0.000681	0.047	CbGpPWpGaD
Glipizide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000669	0.0462	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNB3—nicotine dependence	0.00066	0.0456	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNA6—nicotine dependence	0.000645	0.0446	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNA6—nicotine dependence	0.000626	0.0432	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—GABRA4—nicotine dependence	0.000466	0.0322	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—GABRA4—nicotine dependence	0.000452	0.0312	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNB4—nicotine dependence	0.000447	0.0309	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNB4—nicotine dependence	0.000434	0.03	CbGpPWpGaD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000421	0.0291	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNA5—nicotine dependence	0.000416	0.0287	CbGpPWpGaD
Glipizide—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000415	0.0287	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNA5—nicotine dependence	0.000403	0.0278	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000341	0.0236	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNA3—nicotine dependence	0.000339	0.0234	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNA3—nicotine dependence	0.000329	0.0227	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNB2—nicotine dependence	0.000298	0.0206	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNB2—nicotine dependence	0.000289	0.02	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000278	0.0192	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000278	0.0192	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000274	0.0189	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHRNA4—nicotine dependence	0.000271	0.0187	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHRNA4—nicotine dependence	0.000263	0.0181	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000251	0.0173	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000225	0.0155	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—DRD2—nicotine dependence	0.000206	0.0142	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000192	0.0133	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000181	0.0125	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000179	0.0123	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CCAR1—nicotine dependence	0.000168	0.0116	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000127	0.00876	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00012	0.00826	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000118	0.00814	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2A7—nicotine dependence	0.000117	0.00811	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2A7—nicotine dependence	0.000114	0.00787	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2A7—nicotine dependence	8.42e-05	0.00581	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2A7—nicotine dependence	3.1e-05	0.00214	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.04e-05	0.00141	CbGpPWpGaD
